Breaking News

Botox on the Block?

April 29, 2014

Allergan approaches J&J about a takeover.

Allergan, which owns Botox, has approached Sanofi and Johnson & Johnson and other companies to gauge their interest in acquiring the company.


The reported moves comes after larger rival Valeant Pharmaceuticals joined forces with activist investor Bill Ackman to make an unsolicited $46 billion bid for the Botox maker. Allegan has adopted a poison-pill defense in its efforts to fend off the Valeant takeover, which has prompted analysts at Stifel to downgrade the pharmaceutical company to hold from buy. Shares in Allergan rose 1.2% just after the open.

Related End-User Markets:

Related Raw Materials:

blog comments powered by Disqus
  • Patent Update

    Patent Update

    June 30, 2016
    J&J's anti-aging patent, LVMH and cannabis essential oil, transdermal botulinum toxins and more in recent patent news.

  • Start Stuffing The Ballot Box (Again)!

    Start Stuffing The Ballot Box (Again)!

    June 28, 2016
    Vote on the finalists in Happi's reader's choice Anti-Aging Product of the Year contest!

  • What

    What's Next for the UK?

    Sarah Boumphrey, Euromonitor International||June 27, 2016
    Euromonitor weighs in on how Brexit could impact consumer product companies.

  • Take Notice

    Take Notice

    Melissa Meisel , Associate Editor||June 1, 2016
    Packaging trends revolve around trendy artwork, eco-conscious materials—and portability is a plus too!

  • Virtual Reality

    Virtual Reality

    Christine Esposito, Associate Editor||June 1, 2016
    An update on nature-identical ingredients for cosmetics and personal care products.

  • Shiseido Advances in the US

    Shiseido Advances in the US

    Tom Branna, Editorial Director||June 1, 2016
    New facility in Windsor, NJ demonstrates its dedication to the US and other markets outside Japan.